PR Stories

Paulomi Modi (Ignatius Lab) Recognized as 2023 Presidential Ambassador Scholar

May 8, 2023

Ambassadors from left to right: Gina Baxter (SHP), Avani Ved (SON), Paulomi Modi (GSBS), Alejandra Garcia (LSOM) and Tyler Childs (SOD) Paulomi Modi is a second-year PhD student in the Integrated Biomedical Sciences program at the Graduate School of Biomedical Sciences.  At 17, Modi moved to the United States on her own and later graduated [...]

The Gear Up Against Kids Cancer Rides Again!

January 20, 2023

SAVE-THE-DATE: The Gear Up Against Kids Cancer rides again on April 1st! Check out the updated routes, including a new 60-miler!

Precision Oncology News: Lantern Pharma Preparing IND for Synthetic Lethality Program With FDA Feedback

January 18, 2023

      Jan 17, 2023 | staff reporter NEW YORK – Lantern Pharma on Tuesday said it received feedback from the US Food and Drug Administration that it will use to submit an investigational new drug application for LP-184. The company further plans to begin studying the drug in a Phase I trial of [...]

Luiz Penalva, PhD to Receive Mike Hogg Fund Award

December 15, 2022

Luiz O.F. Penalva, PhD to receive an award from the Mike Hogg Fund in support of his study, “Preventing Senescence Scape to Overcome Tumor Recurrence in Glioblastoma.” Learn more about Dr. Penalva's research

Business Wire: Lantern Pharma to Host Virtual KOL Webinar on the Treatment of Pediatric Cancers During Childhood Cancer Awareness Month, featuring Peter Houghton, Ph.D.

September 20, 2022

Webinar to be hosted on Thursday, Sept. 22, 2022, at 12:00 p.m. ET, register here. Dr. Houghton will discuss challenges in drug development for pediatric cancers and preliminary results from Lantern’s drug candidates in preclinical pediatric cancer models with unmet clinical needs. September 19, 2022 08:50 AM Eastern Daylight Time DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: [...]

Dr. Gupta to Present at American Society for Biochemistry & Molecular Biology 10/1

September 19, 2022

Talk Title: Structured RNAs restrict the N6-adenine methylation (m6dA) activity of human METTL3-METTL14

Congratulations, Dr. Henry Miller!

September 19, 2022

Good afternoon, everyone! Please join us and Dr. Alexander J.R. Bishop in congratulating Henry Miller on his passing his PhD Defense with honors! Way to go Henry!!!!!

UT Health SA Newsroom: The University of Texas Health Science Center at San Antonio moves up in Forbes Best-In-State Employers list

August 31, 2022

Posted on August 29, 2022 at 10:39 am. Shared by Steven Lee Now ranked 12th; fifth among health care/social employers. The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has jumped to 12th on Forbes magazine’s list of Best-In-State Employers 2022, from 34th last year. UT Health San Antonio made the ranking of [...]

Dr. Zhao Lai to Receive NCI R50 Funding

August 24, 2022

The National Cancer Institute (NCI) has recently awarded an R50 Research Specialist Award to Dr. Zhao Lai, Associate Professor/Research, Director of the Next-Generation Sequencing Shared Resource (NGSSR) in the NCI-designated Mays Cancer Center (MCC). This award, over five years, supports the development of a stable research career for Dr. Lai, an exceptional scientist who will [...]